EcoDrugPlus

Phosphodiesterase 5a, Cgmp-Specific, B

Ensembl ID : ENSPFOG00000004961
Gene Symbol: PDE5AB
2 Cross references
219 Possible Orthologues:

Phosphodiesterase 7a

Ensembl ID : ENSPFOG00000005566
Gene Symbol: PDE7A
3 Cross references
227 Possible Orthologues:

Phosphodiesterase 7b

Ensembl ID : ENSPFOG00000011329
Gene Symbol: PDE7B
2 Cross references
189 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 2

Ensembl ID : ENSPFOG00000003942
Gene Symbol: PIK3R2
3 Cross references
189 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 3

Ensembl ID : ENSPFOG00000001877
Gene Symbol: PIK3R3
1 Cross references
147 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 3

Ensembl ID : ENSPFOG00000010141
Gene Symbol: PIK3R3
1 Cross references
206 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 5

Ensembl ID : ENSPFOG00000002198
Gene Symbol: PIK3R5
3 Cross references
200 Possible Orthologues:

Phosphoinositide-3-Kinase, Regulatory Subunit 1 (Alpha)

Ensembl ID : ENSPFOG00000015835
Gene Symbol: PIK3R1
1 Cross references
53 Possible Orthologues:

Phospholipase A2 Group Vii

Ensembl ID : ENSPFOG00000012333
Gene Symbol: PLA2G7
3 Cross references
203 Possible Orthologues:

Phosphoribosylglycinamide Formyltransferase

Ensembl ID : ENSPFOG00000002306
Gene Symbol: GART
1 Cross references
246 Possible Orthologues:

Plasminogen

Ensembl ID : ENSPFOG00000002545
Gene Symbol: PLG
1 Cross references
248 Possible Orthologues:

Plasminogen Activator, Tissue Type

Ensembl ID : ENSPFOG00000013063
Gene Symbol: PLAT
3 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).